Bioseek

Bioseek: Revolutionizing Drug Discovery with Innovative Cell-Based Assays and Services

Bioseek, a subsidiary of DiscoverX, is a leading provider of innovative cell-based assays and services for drug discovery and development. With over 20 years of experience in the industry, Bioseek has established itself as a trusted partner for pharmaceutical companies, biotech firms, and academic institutions worldwide.

At Bioseek, we are committed to advancing drug discovery by providing cutting-edge solutions that enable our clients to make informed decisions at every stage of the drug development process. Our team of experts combines their extensive knowledge in biology, chemistry, pharmacology, and data analysis to deliver high-quality results that meet the unique needs of each client.

Our portfolio includes a wide range of cell-based assays that cover various therapeutic areas such as oncology, inflammation, metabolic disorders, cardiovascular diseases, and more. We offer both off-the-shelf assays as well as custom assay development services tailored to specific project requirements.

One of our flagship products is the BioMAP® platform – a suite of human primary cell-based assays designed to predict the safety and efficacy profile of compounds early in the drug discovery process. The BioMAP® platform integrates multiple readouts such as cytokine profiling, gene expression analysis, imaging-based phenotypic analysis into one comprehensive dataset that provides valuable insights into compound mechanism-of-action (MOA) and potential toxicity issues.

In addition to our assay offerings, we also provide expert consulting services in areas such as target identification/validation strategies; hit-to-lead optimization; lead optimization; preclinical safety assessment; biomarker identification/validation; clinical trial design/execution support.

At Bioseek we pride ourselves on delivering high-quality results with fast turnaround times while maintaining strict adherence to regulatory guidelines. Our state-of-the-art facilities are equipped with advanced instrumentation for high-throughput screening (HTS), flow cytometry analysis (FACS), confocal microscopy imaging (CM), next-generation sequencing (NGS), among others.

We understand that every project is unique – which is why we work closely with our clients from project initiation through completion to ensure their goals are met within budgetary constraints. Our team approach ensures seamless communication between all stakeholders throughout the entire project lifecycle.

In conclusion,

Bioseek's commitment towards revolutionizing drug discovery through innovative cell-based assays has made it an industry leader today. With its vast experience spanning over two decades coupled with its state-of-the-art facilities equipped with advanced instrumentation for HTS,FACS,Cm,and NGS,BioSeek offers customized solutions tailored specifically towards meeting individual client needs across various therapeutic areas like oncology,inflammation ,metabolic disorders ,cardiovascular diseases etc .The company's flagship product -the Biomap platform- integrates multiple readouts like cytokine profiling,gene expression analysis,and imaging based phenotypic analysis into one comprehensive dataset providing valuable insights into compound MOA,potential toxicity issues etc.BioSeek's expert consulting services further add value by offering support across target identification/validation strategies,hit-to-lead optimization ,preclinical safety assessment,biomarker identification/validation,and clinical trial design/execution support.The company prides itself on delivering quality results within fast turnaround times while adhering strictly to regulatory guidelines.BioSeek works closely with clients from initiation through completion ensuring seamless communication between all stakeholders throughout the entire project lifecycle making it an ideal partner for pharmaceutical companies ,biotech firms,and academic institutions worldwide seeking cutting-edge solutions enabling them make informed decisions at every stage during their drug development process .